Verónica Galván

PLoS ONE · 2010

⊕ Open access · CC-BY

Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

▲ 1,033

Neuroscience · 2012

⊕ Preprint · OA

Chronic inhibition of mammalian target of rapamycin by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice

▲ 225

Journal of Cerebral Blood Flow & Metabolism · 2013

⊕ Open access · OA

Chronic Rapamycin Restores Brain Vascular Integrity and Function Through NO Synthase Activation and Improves Memory in Symptomatic Mice Modeling Alzheimer’s Disease

▲ 212

Science Translational Medicine · 2019

⊕ Preprint · OA

Rapamycin and Alzheimer’s disease: Time for a clinical trial?

▲ 171

American Journal of Physiology-Heart and Circulatory Physiology · 2017

⊕ Open access · OA

Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer’s disease and vascular cognitive impairment

▲ 142

Aging Cell · 2015

⊕ Open access · CC-BY

Chronic mTOR inhibition in mice with rapamycin alters T , B , myeloid, and innate lymphoid cells and gut flora and prolongs life of immune‐deficient mice

▲ 128

Experimental Gerontology · 2014

⊕ Open access · CC-BY

How longevity research can lead to therapies for Alzheimer's disease: The rapamycin story

▲ 125

Frontiers in Molecular Neuroscience · 2014

⊕ Open access · CC-BY

Divergent tissue and sex effects of rapamycin on the proteasome-chaperone network of old mice

▲ 95

Aging Cell · 2019

⊕ Open access · CC-BY

mTOR drives cerebrovascular, synaptic, and cognitive dysfunction in normative aging

▲ 79

Journal of Neuroscience · 2021

⊕ Open access · CC-BY

mTOR Attenuation with Rapamycin Reverses Neurovascular Uncoupling and Memory Deficits in Mice Modeling Alzheimer's Disease

▲ 63

Gerontology · 2018

⊕ Open access · OA

A Perfect sTORm: The Role of the Mammalian Target of Rapamycin (mTOR) in Cerebrovascular Dysfunction of Alzheimer's Disease: A Mini-Review

▲ 41

GeroScience · 2023

⊕ Preprint · OA

Rapamycin restores peripheral blood flow in aged mice and in mouse models of atherosclerosis and Alzheimer’s disease

▲ 20

PLoS ONE · 2011

⊕ Open access · CC-BY

Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

▲ 2

PLoS ONE · 2011

⊕ Open access · CC-BY

Correction: Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease

▲ 2

2020

⊕ Open access · CC-BY

Editor's evaluation: In vivo transcriptomic profiling using cell encapsulation identifies effector pathways of systemic aging

▲ 0

Alzheimer s & Dementia · 2011

◌ Citation only

P3‐151: mTOR regulates chaperone networks and cognitive outcomes in mice modeling Alzheimer's disease

▲ 0

Neuroscience · 2015

◌ Citation only

Corrigendum to “Chronic inhibition of mTOR by rapamycin modulates cognitive and non-cognitive components of behavior throughout lifespan in mice” [Neuroscience 223 (2012) 102–113]

▲ 0